These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37446083)

  • 21. Identification and enzymatic characterization of NS2B-NS3 protease of Alkhurma virus, a class-4 flavivirus.
    Bessaud M; Grard G; Peyrefitte CN; Pastorino B; Rolland D; Charrel RN; de Lamballerie X; Tolou HJ
    Virus Res; 2005 Jan; 107(1):57-62. PubMed ID: 15567034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
    Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
    PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
    Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
    Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
    Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH and non-covalent ligand binding modulate Zika virus NS2B/NS3 protease binding site residues: Discoveries from MD and constant pH MD simulations.
    Santos LH; Caffarena ER; Ferreira RS
    J Biomol Struct Dyn; 2022; 40(20):10359-10372. PubMed ID: 34180376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
    Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
    Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
    J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Non-Active-Site Inhibitor with Selectivity for Zika Virus NS2B-NS3 Protease.
    Cruz KG; Hill Eron M; Makhaik S; Savinov S; Hardy JA
    ACS Infect Dis; 2024 Feb; 10(2):412-425. PubMed ID: 38265226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenesis analysis of the NS2B determinants of the Alkhurma virus NS2B-NS3 protease activation.
    Pastorino BAM; Peyrefitte CN; Grandadam M; Thill MCE; Tolou HJ; Bessaud M
    J Gen Virol; 2006 Nov; 87(Pt 11):3279-3283. PubMed ID: 17030861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
    Ren J; Lee H; Kotak A; Johnson ME
    Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
    Niyomrattanakit P; Winoyanuwattikun P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G
    J Virol; 2004 Dec; 78(24):13708-16. PubMed ID: 15564480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
    de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G
    J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease.
    Purohit P; Barik D; Dansana J; Meher BR
    Comput Biol Chem; 2024 Feb; 108():108005. PubMed ID: 38157660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of potential ZIKV NS2B-NS3 protease inhibitors from
    Thirumoorthy G; Tarachand SP; Nagella P; Veerappa Lakshmaiah V
    J Biomol Struct Dyn; 2022; 40(21):11203-11215. PubMed ID: 34319220
    [No Abstract]   [Full Text] [Related]  

  • 39. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
    Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
    J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.